It is common for a NE prostate cancer phenotype to not express AR and PSA and common for amplification of the genes aurora kinase A (AURKA) and N-myc (MYCN (51), both of which were overexpressed in ACRJ-PC28 at RNA-seq level and MYC was detected at the protein level. The gene discussed is MYCN; the disease is prostate carcinoma.